Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Cancer Res. 2017 Nov 29;78(3):830–839. doi: 10.1158/0008-5472.CAN-17-1229

Figure 3.

Figure 3

Probability density function for the log10 sizes of subclones carrying driver mutations present in the clinically detectable simulated tumors for each combination of parameter values; N is the number of clinically detectable tumors generated by the model. The distribution has a heavy right tail with only a few dominant clones present at ≥10% frequency, composing most of the tumor cell population (Fig. 2A), and with the majority of subclones present at frequencies below the detection limit of standard sequencing techniques.